ClosingPast Due

Enterprise Cost Optimization Consolidation

ID: 2744372-10

Potential Value

$25,176,021

Deal Value

$0

Stated Probability

50%

Days in Pipeline

203

Client & Account

Client

Onyx Pharmaceutical Innovations

City

Boston

Region

USLI

Sub-Sector

SLED

Service Classification

Service Line

Assurance

Field of Play

Risk

Opportunity Sub-SL

Forensics

Competency

Incident Response & Resilience

Global Service Code

Mediation Services (94774)

People & Dates

Partner

Fischer Olivier

Pursuit Leader

Ross Diana

Open Date

Oct 22, 2025

Anticipated Win Date

Mar 31, 2026

Close Date

N/A

Details

Description

Enterprise Cost Optimization Consolidation

No win probability predictions available for this opportunity.